ADARx Pharmaceuticals
Latest round
- Series C
Last raised
- Aug 2023
Total raised
- $321M
Investors
- 17
About ADARx Pharmaceuticals
Based in California, US, and founded in 2019 by Dr. Zhen Li, ADARx Pharmaceuticals, Inc. is a biotechnology company that develops RNA targeting therapeutics for treating diseases including genetic, cardiometabolic, and central nervous system diseases. In August 2023, ADARx Pharmaceuticals, Inc. Rowe Price Associates, Venrock Healthcare Capital Partners, and Vivo Capital. ADARx Pharmaceuticals' platform helps discover and develop genetic therapeutics that target and edit single point mutations on RNA transcripts enabling the production of desired proteins for the treatment of diseases with a genetic mutation. The RNA targeting platform includes oligonucleotides for inhibition, degradation, and editing, together with novel oligonucleotide delivery technologies.
Who invested in ADARx Pharmaceuticals
17 investors across 3 rounds
See all investors in ADARx Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ADARx Pharmaceuticals
Who invested in ADARx Pharmaceuticals?
ADARx Pharmaceuticals has 17 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ADARx Pharmaceuticals raised?
ADARx Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ADARx Pharmaceuticals last raise money?
ADARx Pharmaceuticals's most recent round on record is a Series C, in Aug 2023.
What does ADARx Pharmaceuticals do?
Based in California, US, and founded in 2019 by Dr.
Where is ADARx Pharmaceuticals headquartered?
ADARx Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like ADARx Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ADARx Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like ADARx Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.